Michael Wiggins De Oliveira, author at Seeking Alpha, discusses health supplement retailer GNC as his "Idea of the Month."
He notes that even though the company is in debt by more than $1 billion, it's still a buy for him because of the measures the company is taking to wipe out the debt, including the $200 million in annual free cash flow.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
Eliott Wellenbach, vice president and institutional ETF strategist with Direxion, joined Cheddar News to discuss what traders are expecting from consumer spending ahead of the holidays and how they're positioning themselves following the latest inflation data and mortgage rates.
